Wedbush Reiterates an 'Outperform' on AVI BioPharma (AVII); Sell-Off Misses Point; Higher Dose Hit Endpoint

Go back to Wedbush Reiterates an 'Outperform' on AVI BioPharma (AVII); Sell-Off Misses Point; Higher Dose Hit Endpoint
AVI BioPharma, Inc. (NASDAQ: AVII) Delayed: 0.66 --0 (-0%)
Previous Close $0.66    52 Week High $1.68 
Open $71.89    52 Week Low $0.43 
Day High $0.66    P/E N/A 
Day Low $0.66    EPS $-0.16 
Volume 38,332